Novel FGFR Inhibitors
  • A new type, multiple-function targeted small molecule inhibitor. It has an excellent inhibitory effect especially on drug-resistant bladder cancer cells by selectively acting on the fibroblast growth factor receptor (FGFR).
  • Less toxicity and side effects comparing with previous generation compounds.
  • Applied for related patents and global layout.
Scroll to Top